PSTV - Plus Therapeutics to Announce Third Quarter 2023 Financial Results and Host Conference Call on October 31 2023 | Benzinga
AUSTIN, Texas, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today announced that the Company will report third quarter 2023 financial results on Tuesday, October 31, 2023, after market close. Plus Therapeutics' management team will then host a conference call and webcast at 5:00 p.m. ET to discuss the financial results and provide a corporate update.
| Conference Call & Webcast |
| Tuesday, October 31, 2023 @ 5:00 PM ET |
| Dial in #: |
| https://register.vevent.com/register/BI484eba10ce0d4bc292c51db6fc396f0c |
| Webcast: |
| https://edge.media-server.com/mmc/p/vt5rg89x |
Participants may also pre-register any time before the call through the dial in # link. Once registration is completed, participants will be provided a dial-in number with a personalized conference code to access the call. Please dial in 15 minutes prior to the start time.
Following the live call, a replay will be available on the Company's website under the ‘For Investors' section. The webcast will be available on the Company's website for 90 days following the live call.
About Plus Therapeutics
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes for patients. Combining image-guided local ...